Clinical Trial Update: Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial completed by McMaster University studied alendronate to prevent and treat osteoporosis in cystic fibrosis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis
• Osteoporosis

Drugs mentioned

• alendronate (alendronate)

Snippet

Sponsor: McMaster University | Conditions: Cystic Fibrosis, Osteoporosis | Phase 4 | Status: COMPLETED